50.865 -

+0.765 (+1.53%)
Range 50.755 - 51.090   (0.66%)
Open 50.800
Previous Close 50.100
Bid Price 50.860
Bid Volume 198
Ask Price 50.870
Ask Volume 100
Volume 3,661,024
Value 127,437,707
Remark -
Delayed prices. Updated at 30 Jan 2026 03:15.
Data powered by
View All Events

About GSK Sp ADR

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK�s principal pharmaceutical products include medicines in therapeutic areas: respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines and human immunodeficiency virus (HIV). The Company operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. On January 30, 2013, GSK acquired additional 29.3% interest in GlaxoSmithKline Consumer Healthcare Ltd. In May 2013, GlaxoSmithKline PLC acquired Okairos AG. In December 2013, Suntory Beverage & Food Ltd fully acquired Lucozade Ribena Suntory Limited from GlaxoSmithKline plc.

There are 30 followers

Followers
0
Followers
56
Followers
2
Followers
2
Followers
0
Followers
0
Followers
0
dj0
Followers
0
Followers
43
Followers
1
Followers
0
Followers
0
Followers
6
Followers
1
Followers
2
Followers
0
trader
Followers
10
Followers
0
Followers
0
Followers
13
Followers
1
Followers
0
Followers
3
Followers
13
Followers
0
Followers
0
Followers
0
Followers
0
Followers
0
Followers
0